What is the treatment for thrush?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Thrush

For uncomplicated vulvovaginal candidiasis (thrush), either topical azole antifungals applied intravaginally or a single 150 mg oral dose of fluconazole are equally effective first-line treatments, with topical agents achieving 80-90% cure rates. 1

Uncomplicated Vulvovaginal Candidiasis

First-Line Treatment Options

Topical intravaginal azole therapy is highly effective, with multiple equivalent options available 1:

  • Short-course regimens (1-3 days) are as effective as longer courses for uncomplicated cases 1
  • Clotrimazole 1% cream 5g intravaginally for 7-14 days 1
  • Clotrimazole 100 mg vaginal tablet for 7 days 1
  • Clotrimazole 500 mg vaginal tablet as single application 1
  • Miconazole 2% cream 5g intravaginally for 7 days 1, 2
  • Miconazole 200 mg vaginal suppository for 3 days 1
  • Terconazole 0.8% cream 5g intravaginally for 3 days 1
  • Butoconazole 2% cream 5g intravaginally for 3 days 1

Oral fluconazole 150 mg as a single dose is equally effective as topical therapy and offers superior convenience 1, 3. Clinical cure or improvement occurs in 94% of patients by day 14, with mycologic cure in 77% 3.

Important caveat: Topical azole creams and suppositories are oil-based and may weaken latex condoms and diaphragms 1, 2. Patients should avoid vaginal intercourse during treatment 2.

Alternative Agents

  • Nystatin 100,000-unit vaginal tablet daily for 14 days is less effective than azoles but remains an option 1
  • Topical azoles are more effective than nystatin, with azoles achieving significantly better outcomes 4

Severe or Complicated Vulvovaginal Candidiasis

For severe acute disease, fluconazole 150 mg every 72 hours for 2-3 total doses is recommended 1.

Non-albicans Candida Species

For C. glabrata vulvovaginitis unresponsive to oral azoles 1:

  • Boric acid 600 mg intravaginally daily for 14 days (administered in gelatin capsule) 1
  • Nystatin intravaginal suppositories 100,000 units daily for 14 days 1
  • Topical 17% flucytosine cream alone or combined with 3% amphotericin B cream daily for 14 days 1

Recurrent Vulvovaginal Candidiasis

For recurrent infections (≥4 episodes per year), use 10-14 days of induction therapy with topical agent or oral fluconazole, followed by fluconazole 150 mg weekly for 6 months as maintenance 1.

Oropharyngeal Candidiasis (Oral Thrush)

For mild oropharyngeal candidiasis affecting the mouth and lips 5:

  • Clotrimazole troches 10 mg used 5 times daily for 7-14 days 5
  • Miconazole mucoadhesive buccal 50 mg tablet applied to mucosal surface over canine fossa once daily for 7-14 days 5

Alternative topical options 5:

  • Nystatin suspension (100,000 U/mL) 4-6 mL four times daily for 7-14 days 5
  • Nystatin pastilles (200,000 U each) 1-2 pastilles four times daily for 7-14 days 5

For moderate to severe oropharyngeal candidiasis, oral systemic therapy with fluconazole 100-200 mg daily for 7-14 days is preferred over topical options 5. Single-dose fluconazole 150 mg has shown 96.5% efficacy for oral thrush in palliative care patients 6.

Treatment Duration Considerations

  • Pregnancy: Seven-day treatment courses are necessary rather than shorter regimens used in non-pregnant women 4
  • General population: Treatment should continue until clinical resolution, typically 7-14 days 5
  • Most patients experience symptom improvement within 1 day but require the full 7-day course for complete relief 2

Key Clinical Pitfalls

Avoid self-treatment without prior diagnosis 2:

  • Women should only self-treat with over-the-counter preparations if previously diagnosed by a physician and experiencing identical recurrent symptoms 1
  • Symptoms persisting beyond 3 days or lasting more than 7 days require physician evaluation 2

Red flags requiring immediate medical evaluation 2:

  • Lower abdominal, back, or shoulder pain with fever, chills, nausea, vomiting, or foul-smelling discharge (may indicate pelvic inflammatory disease) 2
  • Recurrent infections (≥3 episodes in 6 months) suggesting underlying conditions like diabetes or immunosuppression 2

Treatment failure considerations 1:

  • Patients with history of recurrent vaginitis are significantly less likely to respond to standard therapy (p < 0.001) 3
  • For fluconazole-refractory oropharyngeal disease, use amphotericin B deoxycholate oral suspension 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Topical treatment for vaginal candidiasis (thrush) in pregnancy.

The Cochrane database of systematic reviews, 2001

Guideline

Topical Antifungal Medications for Lip Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Single-Dose Fluconazole Therapy for Oral Thrush in Hospice and Palliative Medicine Patients.

The American journal of hospice & palliative care, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.